Pneumococcal mastoiditis in children and the emergence of multidrug-resistant serotype 19A isolates

Julina Ongkasuwan1, Tulio A Valdez, Kristina G Hulten

  • 1Bobby R. Alford Department of Otolaryngology-Head and Neck Surgery, Baylor College of Medicine, Houston, Texas, USA.

Pediatrics
|July 4, 2008
PubMed

Insights

The pneumococcal conjugate vaccine

Area of Science:

  • Pediatric infectious diseases
  • Vaccinology
  • Otolaryngology

Background:

  • Pneumococcal mastoiditis is a serious complication of otitis media in children.
  • The pneumococcal conjugate vaccine (PCV) was introduced to reduce the burden of invasive pneumococcal disease.
  • Serotype 19A has emerged as a significant pathogen in invasive pneumococcal disease following PCV introduction.

Purpose of the Study:

  • To evaluate the impact of the pneumococcal conjugate vaccine on pneumococcal mastoiditis in children.
  • To identify changes in serotype prevalence and clinical characteristics of pneumococcal mastoiditis post-vaccine introduction.

Main Methods:

  • Retrospective review of medical charts of children with pneumococcal mastoiditis from 1995 to 2007.
  • Serotyping of pneumococcal isolates using the capsular swelling method.
  • Pulsed-field gel electrophoresis and multilocus sequence typing for characterizing 19A isolates.

Main Results:

  • Serotype 19A became the predominant cause of pneumococcal mastoiditis after PCV introduction.
  • Cases caused by 19A were more likely to present with subperiosteal abscess and require mastoidectomy.
  • Multidrug resistance was common in 19A isolates, associated with clonal complex 271.

Conclusions:

  • Serotype 19A, particularly multidrug-resistant strains of clonal complex 271, has emerged as a leading cause of pneumococcal mastoiditis in children.
  • Pneumococcal mastoiditis due to 19A is associated with more severe clinical presentations, including subperiosteal abscesses and increased need for mastoidectomy.
Abstract

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...